로딩 중…
지수 로딩 중…
Zymeworks Inc.
ZYME· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CA
CA$23.14+0.00%
2026-06-18
Price Chart
Zymeworks Inc.+83.21%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.70B |
| Revenue | $81M |
| Net Income | $-103M |
| Total Assets | $478M |
| Net Assets | $164M |
| Value | |
| P/B | 10.41x |
| P/S | 20.95x |
| FCF Yield | -4.53% |
| Profitability | |
| ROE | -62.75% |
| ROA | -21.47% |
| Op. Margin | -140.35% |
| Revenue Growth | -91.12% |
| Financial Health | |
| Debt Ratio | 192.33% |
| Total Debt | $17M |
| FCF | $-77M |
| Cash | $244M |
| Current Ratio | 10.82x |
| Performance | |
| 1Y Return | 83.21% |
| 1M Return | -5.16% |
| From 52W High | -22.22% |
| 1Y MDD | -21.25% |
| Trading | |
| Volume | 687,323 shares |
| Trading Value | $16M |
| Per Share | |
| EPS | $-1.08 |
| BPS | $3.56 |